Normohomocysteinaemia and vitamin-treated hyperhomocysteinaemia are associated with similar risks of cardiovascular events in patients with premature atherothrombotic cerebrovascular disease: A prospective cohort study

Netherlands Journal of Medicine

Volumn 56, Issue 4, 2000, Pages 138-146

  Vermeulen, Erik G J ^a   Rauwerda, Jan A ^a   Erix, Patrick ^a   De Jong, Sylvia C ^a   Twisk, Jos W R ^a   Jakobs, Carel ^a   Witjes, Ron J G M ^a,b   Stehouwer, Coen D A ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b Gooi Noord Hospital   (Netherlands)

Author keywords

Aherothrombotic cerebrovascular disease; Cardiovascular events; Hyperhomocysteinaemia; Prospective study; Vitamin treatment

Indexed keywords

FOLIC ACID; PYRIDOXINE;

ADULT; ARTICLE; CARDIOVASCULAR RISK; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; DRUG EFFICACY; FEMALE; HUMAN; HYPERHOMOCYSTEINEMIA; INCIDENCE; MAJOR CLINICAL STUDY; MALE; OCCLUSIVE CEREBROVASCULAR DISEASE; PROGNOSIS; TREATMENT OUTCOME;

ADULT; ARTERIOSCLEROSIS; CEREBROVASCULAR ACCIDENT; FEMALE; FOLIC ACID; FOLLOW-UP STUDIES; HEMATINICS; HUMANS; HYPERHOMOCYSTEINEMIA; ISCHEMIC ATTACK, TRANSIENT; MALE; MASS SCREENING; METHIONINE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; PYRIDOXINE; RISK ASSESSMENT; RISK FACTORS; TREATMENT OUTCOME;

EID: 0034112925     PISSN: 03002977     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0300-2977(00)00010-3     Document Type: Article

References (26)